Gilead Sciences Inc
BMV:GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
BMV:GILD
|
US |
|
M
|
Marsh & McLennan Companies Inc
LSE:MHM
|
US |
|
M
|
Marsh & McLennan Companies Inc
SWB:MSN
|
US |
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
X
|
Xior Student Housing NV
LSE:0RD8
|
BE |
|
Avi Ltd
F:IZ60
|
ZA |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
F
|
Firefinch Ltd
F:N9F
|
AU |
|
U
|
UPM-Kymmene Oyj
F:RPL
|
FI |
|
OSE Immunotherapeutics SA
F:6OP
|
FR |
|
S
|
Schroders PLC
XBER:PYXA
|
UK |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
Wall St Price Targets
GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GILD is 2 894.97 MXN with a low forecast of 2 219.93 MXN and a high forecast of 3 377.34 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GILD's stock price target?
Price Target
2 894.97
MXN
According to Wall Street analysts, the average 1-year price target for GILD is 2 894.97 MXN with a low forecast of 2 219.93 MXN and a high forecast of 3 377.34 MXN.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 8 years is 10%.
